|
PROSPECTUS SUPPLEMENT |
|
Filed Pursuant to Rule 424(b)(3) |
|
Dated January 22, 2020 |
|
Registration No. 333-232858 |
PROSPECTUS SUPPLEMENT
DATED JANUARY 22, 2020
TO PROSPECTUS DATED
AUGUST 27, 2019 OF
ARCADIA BIOSCIENCES, INC.
1,564,054 SHARES
COMMON STOCK
The final prospectus of Arcadia Biosciences, Inc. dated August 27, 2019 is supplemented to include the following updated information:
Selling Stockholders Table
The “Selling Stockholders” table contained in the final prospectus dated August 27, 2019 is revised as follows to reflect a transfer by Michael Vasinkevich of a warrant to purchase 48,039 shares of our common stock to OTA LLC. Except as amended by this prospective supplement to reflect this transfer, the “Selling Stockholders” table contained in the final prospectus is not otherwise affected by this prospectus supplement. Percentage of beneficial ownership is based on approximately 8,646,149 shares of our common stock outstanding as of January 21, 2020.
|
|
|
Shares Beneficially Owned Before |
|
Shares to be Sold in |
|
|
Shares Beneficially Owned After Offering |
|||
|
Name of Selling Stockholder |
|
this Offering |
|
this Offering |
|
|
Number |
|
Percentage |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OTA LLC (1) |
|
48,039 (2) |
|
|
48,039 |
|
|
— |
|
— |
______________
|
(1) |
OTA LLC is a registered broker dealer. The natural person who has voting and dispositive power over the shares beneficially held by OTA LLC is Ira M. Leventhal. |
|
(2) |
Includes 48,039 shares of common stock issuable upon exercise of a warrant. |